In Conversation with Ariel Katz: Guest, Robert Stevens, Principal at RS Consultative

Medical Affairs continues to evolve in all ways. It’s becoming strategically a more important pillar within pharma orgs and a bridge between R&D and Commercial. Robert Stevens, a seasoned veteran of this space, consults with Pharma around the world to advise on digital BD&L, new product offerings, commercial models, and digital & data strategy. He recently spent time with H1 CEO, Ariel Katz discussing important topics including:

  • The changing role of Medical Affairs
  • How AI and RWE impact life sciences
  • Investing in data to understand the impact pharma is having on outcomes
  • Philosophies around measuring the impact Medical Affairs has on bringing new therapies to market

Listen to the full convo for some great insights: